• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Pharm Exec 50: The Winners’ Circle

Article

Pharmaceutical Executive

Pharmaceutical ExecutivePharmaceutical Executive-05-01-2008
Volume 0
Issue 0

Your guide to the world's top 50 pharma companies. The giants may be struggling, but even in a tough year, the industry's most successful companies know how to hit the bullseye.

External Link - article-531367.pdf

Articles in this issue
Pharm Exec 50: The Winners’ Circle
i2-523694-1408670090148.gif
How Not to Handle Rebates
i1-517394-1408675958982.jpg
Want to Be in a Health Plan? Think Like One
i8_t-517402-1408675941187.jpg
Special Report: Platform Drugs—Marketing Your Opportunities
i1-517396-1408675955735.jpg
Bringing in the Green
i1-517397-1408675953916.jpg
Boundaries of Expanded Access
i3_t-517399-1408675949623.jpg
Q&A with Barbara Yanni
i1-517390-1408675966395.jpg
Ready, Aim, Sell
i1-517395-1408675957155.jpg
Are You Exposed? Lock Data Down Now
i1-517391-1408675964917.jpg
Staying in the Game
i1-517389-1408675968608.jpg
For the People, By the People
i4-517400-1408675947316.jpg
Under Pressure
i1-517387-1408675972097.jpg
Korea's Dream Market
i1-517388-1408675970785.jpg
Beyond the Norm
i1-517401-1408675944965.jpg
Special Report: Platform Drugs—Opportunities in the Market...
Recent Videos
Related Content
Kirsten Jacobs

The Lifespan of Mature Drugs in 2025: Q&A with Kirsten Jacobs

Mike Hollan
December 18th 2024
Article

PharmaLex’s chief strategy officer discusses strategies to improve monetization for these drugs.

Seeking More Value, Less Cost

Seeking More Value, Less Cost

Michael Christel
December 17th 2024
Article

The biosimilars market in the US is on the rise, but barriers to greater adoption remain.

Dealmaking Dormant No More

Dealmaking Dormant No More

Mike Hollan
December 17th 2024
Article

Unleashed demand over the past year characterizes the M&A picture in pharma.

The Recipe for Relief: Overcoming Industry Pain Points

The Recipe for Relief: Overcoming Industry Pain Points

Diane Petrone
December 13th 2024
Article

Why investing in people and training can help drugmakers deal with six pressing challenges in particular in the year ahead.

Pharma Forecasting: Key Markets Investors Can’t Ignore

Pharma Forecasting: Key Markets Investors Can’t Ignore

Na Wei;Joerg Tritschler;Martin Slusarczyk, PhD
December 13th 2024
Article

The importance of expanding your pharma sales forecasting horizon beyond the US. Learn how to effectively navigate country-specific regulatory red flags.

Introducing Agentic AI: Its Revolutionary Potential in Pharma

Introducing Agentic AI: Its Revolutionary Potential in Pharma

Tanveer Ahmed Nasir;Pooja Jain
December 13th 2024
Article

A look at the promise and opportunities from this new and advanced type of AI in transforming commercial planning and execution for life sciences companies.